Oskar Hansson Selected Research

7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indole

1/2022	The BIN1 rs744373 Alzheimer's disease risk SNP is associated with faster Aβ-associated tau accumulation and cognitive decline.
1/2021	The impact of demographic, clinical, genetic, and imaging variables on tau PET status.
1/2021	A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis.
1/2021	Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts.
1/2021	Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
1/2020	[18F]Flortaucipir distinguishes Alzheimer's disease from progressive supranuclear palsy pathology in a mixed-pathology case.
1/2020	Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
1/2020	Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
1/2020	Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948.
1/2020	Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oskar Hansson Research Topics

Disease

220	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 03/2006
104	Cognitive Dysfunction 05/2022 - 03/2006
97	Dementia (Dementias) 11/2022 - 06/2010
32	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2011
29	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 04/2003
21	Atrophy 02/2022 - 10/2016
13	Disease Progression 01/2022 - 04/2003
9	Amyloid Plaque 01/2022 - 12/2010
9	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022 - 09/2014
8	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2020 - 01/2013
8	Parkinsonian Disorders (Parkinsonism) 01/2020 - 11/2012
7	Neuroinflammatory Diseases 01/2022 - 01/2012
6	Tauopathies 12/2021 - 01/2017
5	Frontotemporal Dementia (Semantic Dementia) 10/2022 - 01/2016
5	Neurobehavioral Manifestations 06/2022 - 10/2014
5	Synucleinopathies 01/2022 - 01/2013
5	Pain (Aches) 01/2022 - 06/2013
5	Pathologic Processes 01/2018 - 06/2010
4	Gliosis 01/2022 - 01/2019
4	Inflammation (Inflammations) 01/2022 - 06/2011
4	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 01/2011
3	Multiple System Atrophy 01/2022 - 01/2013
3	Prodromal Symptoms 01/2021 - 01/2017
3	Fatigue 01/2015 - 01/2012
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 11/2022 - 01/2013
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 01/2021
2	Acute-Phase Reaction 01/2022 - 01/2021
2	Osteoarthritis 01/2022 - 01/2020
2	Clinical Deterioration 12/2021 - 11/2021
2	COVID-19 04/2021 - 01/2020
2	Amyloidosis 01/2020 - 03/2016
2	Primary Progressive Aphasia 01/2020 - 11/2018
2	Brain Injuries (Brain Injury) 01/2018 - 05/2013
2	Stroke (Strokes) 01/2017 - 02/2015
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2015 - 01/2011
2	Chronic Disease (Chronic Diseases) 10/2013 - 01/2012
2	Huntington Disease (Huntington's Disease) 04/2003 - 03/2002
1	Schizophrenia (Dementia Praecox) 10/2022
1	Treatment-Resistant Schizophrenia 10/2022
1	Genetic Risk Score 05/2022
1	Down Syndrome (Down's Syndrome) 01/2022

Drug/Important Bio-Agent (IBA)

166	Biomarkers (Surrogate Marker)IBA 11/2022 - 03/2006
119	Amyloid (Amyloid Fibrils)IBA 05/2022 - 08/2008
35	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2003
26	Apolipoproteins E (ApoE)IBA 05/2022 - 03/2006
19	Amyloid beta-PeptidesIBA 06/2022 - 01/2007
19	Peptides (Polypeptides)IBA 12/2020 - 01/2007
15	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2022 - 08/2017
10	ApolipoproteinsIBA 05/2022 - 01/2013
10	SynucleinsIBA 01/2022 - 01/2013
9	Pharmaceutical PreparationsIBA 10/2021 - 11/2014
9	flutemetamolIBA 01/2021 - 10/2014
7	tau Proteins (tau Protein)IBA 01/2022 - 01/2016
7	NeurograninIBA 01/2020 - 11/2010
6	Glial Fibrillary Acidic ProteinIBA 06/2022 - 01/2011
6	EnzymesIBA 01/2019 - 08/2008
6	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2011
5	Threonine (L-Threonine)FDA Link 01/2022 - 01/2019
4	Pemetrexed (MTA)FDA Link 02/2022 - 04/2019
4	LigandsIBA 01/2022 - 01/2012
4	Biological ProductsIBA 11/2018 - 01/2007
3	florbetapirIBA 11/2020 - 04/2016
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020 - 01/2008
3	Blood Proteins (Serum Proteins)IBA 01/2020 - 01/2012
3	ImmunosorbentsIBA 04/2016 - 10/2015
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 01/2020
2	Inositol (Myoinositol)IBA 01/2022 - 05/2016
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 01/2022 - 01/2015
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022 - 01/2020
2	FluorineIBA 01/2021 - 01/2021
2	Cholinergic Agents (Cholinergics)IBA 01/2020 - 01/2013
2	Lipocalin-2IBA 01/2020 - 01/2011
2	Amino Acids FDA Link 01/2020 - 06/2013
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 03/2002
2	UbiquitinIBA 01/2019 - 12/2017
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2018 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 08/2017
2	Antihypertensive Agents (Antihypertensives)IBA 01/2017 - 07/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 11/2015
2	CytokinesIBA 01/2013 - 01/2012
2	Natriuretic PeptidesIBA 07/2011 - 04/2011
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2010 - 01/2009
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 02/2004 - 04/2003
1	Clozapine (Clozaril)FDA LinkGeneric 10/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2022
1	Hydroxyindoleacetic AcidIBA 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022
1	Death Domain ReceptorsIBA 04/2021
1	RNA (Ribonucleic Acid)IBA 04/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 04/2021
1	Ceruloplasmin (Ferroxidase)IBA 01/2021
1	HemopexinIBA 01/2021
1	HaptoglobinsIBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021

Therapy/Procedure

16	Therapeutics 01/2022 - 12/2010
3	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2022 - 01/2020
2	Home Nursing (Nursing, Home) 01/2022 - 01/2021